Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDKF5503/58
CompoundTapentadol
Trials sponsorGrünenthal GmbH
Trial phase3
Brief titleComparison of increasing doses of tapentadol versus a combination of tapentadol and pregabalin
IndicationLow back pain, Chronic Pain, Neuropathic Pain
UTN
CTG IDNCT01352741
CTIS ID (former EudraCT)2010-019998-14
Trial statusCompleted
FPIMarch 23, 2011
LPOJanuary 17, 2012
CountriesGermany, Poland, Romania, Austria, Belgium, Denmark, Netherlands, Spain
GenderAll
Age>18
ResultsYes
Pubmed24738609
24750558
Documents
KF5503-58 | Grünenthal